Concepts (268)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dendritic Cells | 20 | 2021 | 509 | 4.430 |
Why?
|
| Lupus Erythematosus, Systemic | 11 | 2024 | 159 | 4.260 |
Why?
|
| Interferon Type I | 7 | 2022 | 169 | 2.150 |
Why?
|
| Lupus Nephritis | 3 | 2024 | 33 | 1.620 |
Why?
|
| Autoantibodies | 8 | 2024 | 175 | 1.420 |
Why?
|
| Biofilms | 6 | 2024 | 69 | 1.410 |
Why?
|
| Interferon-alpha | 3 | 2024 | 98 | 1.220 |
Why?
|
| Autoimmunity | 5 | 2022 | 224 | 1.160 |
Why?
|
| DNA | 3 | 2024 | 794 | 1.100 |
Why?
|
| Receptor, ErbB-2 | 2 | 2024 | 51 | 1.040 |
Why?
|
| STAT2 Transcription Factor | 7 | 2020 | 7 | 1.040 |
Why?
|
| Signal Transduction | 9 | 2021 | 2891 | 0.970 |
Why?
|
| Macrophage Activation Syndrome | 1 | 2024 | 5 | 0.900 |
Why?
|
| ErbB Receptors | 1 | 2024 | 113 | 0.890 |
Why?
|
| Vibrio cholerae | 1 | 2023 | 11 | 0.870 |
Why?
|
| Animals | 36 | 2024 | 19663 | 0.860 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 170 | 0.850 |
Why?
|
| Toll-Like Receptor 9 | 4 | 2019 | 197 | 0.820 |
Why?
|
| Mice | 30 | 2024 | 10280 | 0.810 |
Why?
|
| Cytokines | 8 | 2024 | 906 | 0.740 |
Why?
|
| Interleukin-4 | 2 | 2014 | 138 | 0.730 |
Why?
|
| Immunity, Innate | 4 | 2024 | 766 | 0.710 |
Why?
|
| Autoantigens | 2 | 2019 | 125 | 0.690 |
Why?
|
| Receptor, Interferon alpha-beta | 2 | 2019 | 45 | 0.690 |
Why?
|
| Myeloid Cells | 2 | 2012 | 92 | 0.660 |
Why?
|
| Mice, Inbred C57BL | 17 | 2023 | 3195 | 0.660 |
Why?
|
| Interleukin-27 | 1 | 2019 | 5 | 0.660 |
Why?
|
| Epoxy Compounds | 1 | 2019 | 9 | 0.660 |
Why?
|
| Toll-Like Receptors | 3 | 2019 | 434 | 0.650 |
Why?
|
| Furans | 1 | 2019 | 36 | 0.650 |
Why?
|
| Pyruvates | 1 | 2019 | 3 | 0.650 |
Why?
|
| Immunomodulation | 1 | 2019 | 27 | 0.640 |
Why?
|
| Interferon-beta | 3 | 2014 | 76 | 0.620 |
Why?
|
| Interleukin-10 | 1 | 2019 | 147 | 0.610 |
Why?
|
| Salmonella typhimurium | 4 | 2022 | 80 | 0.610 |
Why?
|
| Bacterial Infections | 1 | 2019 | 139 | 0.600 |
Why?
|
| Macrophage-1 Antigen | 2 | 2008 | 31 | 0.590 |
Why?
|
| Fatty Acids | 1 | 2019 | 194 | 0.590 |
Why?
|
| Up-Regulation | 4 | 2018 | 364 | 0.580 |
Why?
|
| Estradiol | 2 | 2018 | 242 | 0.570 |
Why?
|
| Cross-Priming | 2 | 2020 | 16 | 0.570 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2017 | 31 | 0.570 |
Why?
|
| Energy Metabolism | 1 | 2019 | 349 | 0.530 |
Why?
|
| Cells, Cultured | 9 | 2021 | 2104 | 0.510 |
Why?
|
| Salmonella Infections | 4 | 2023 | 38 | 0.510 |
Why?
|
| Inflammation | 4 | 2023 | 1102 | 0.480 |
Why?
|
| Spleen | 3 | 2019 | 485 | 0.480 |
Why?
|
| Amyloid | 4 | 2022 | 62 | 0.470 |
Why?
|
| Lentivirus Infections | 1 | 2014 | 1 | 0.460 |
Why?
|
| Exodeoxyribonucleases | 1 | 2014 | 28 | 0.450 |
Why?
|
| Mice, Knockout | 9 | 2016 | 1989 | 0.450 |
Why?
|
| Disease Models, Animal | 6 | 2024 | 2069 | 0.450 |
Why?
|
| DNA, Bacterial | 3 | 2024 | 260 | 0.440 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2014 | 97 | 0.430 |
Why?
|
| Lymphocyte Activation | 4 | 2019 | 741 | 0.420 |
Why?
|
| Phosphoproteins | 1 | 2014 | 216 | 0.410 |
Why?
|
| Membrane Glycoproteins | 2 | 2014 | 669 | 0.410 |
Why?
|
| Interferons | 1 | 2012 | 64 | 0.390 |
Why?
|
| NF-kappa B | 1 | 2014 | 461 | 0.390 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 646 | 0.380 |
Why?
|
| Cellular Senescence | 1 | 2012 | 104 | 0.380 |
Why?
|
| Opsonin Proteins | 2 | 2008 | 31 | 0.380 |
Why?
|
| Mice, Inbred NZB | 3 | 2024 | 19 | 0.370 |
Why?
|
| Humans | 25 | 2024 | 59527 | 0.370 |
Why?
|
| Microbiota | 2 | 2023 | 106 | 0.330 |
Why?
|
| STAT1 Transcription Factor | 4 | 2014 | 35 | 0.330 |
Why?
|
| Bacterial Proteins | 4 | 2022 | 749 | 0.320 |
Why?
|
| Kidney | 3 | 2024 | 395 | 0.320 |
Why?
|
| Ligands | 3 | 2019 | 422 | 0.320 |
Why?
|
| Complement C3b | 1 | 2008 | 20 | 0.310 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2023 | 196 | 0.310 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 675 | 0.310 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2019 | 72 | 0.310 |
Why?
|
| Imidazoles | 3 | 2019 | 83 | 0.300 |
Why?
|
| Gene Expression Regulation | 3 | 2021 | 1538 | 0.300 |
Why?
|
| Female | 15 | 2024 | 30924 | 0.290 |
Why?
|
| Th2 Cells | 1 | 2007 | 98 | 0.290 |
Why?
|
| Lipopolysaccharides | 3 | 2019 | 645 | 0.280 |
Why?
|
| Cell Survival | 2 | 2019 | 557 | 0.280 |
Why?
|
| Fibrosis | 2 | 2024 | 151 | 0.270 |
Why?
|
| Paracrine Communication | 2 | 2021 | 14 | 0.270 |
Why?
|
| Lupus Vulgaris | 1 | 2006 | 3 | 0.260 |
Why?
|
| Apoptosis | 3 | 2021 | 1039 | 0.250 |
Why?
|
| Autoimmune Diseases | 3 | 2022 | 224 | 0.250 |
Why?
|
| Antibodies, Antinuclear | 2 | 2020 | 36 | 0.240 |
Why?
|
| Quinazolines | 1 | 2024 | 22 | 0.230 |
Why?
|
| Antibodies, Monoclonal | 2 | 2020 | 874 | 0.230 |
Why?
|
| Phenotype | 2 | 2021 | 1157 | 0.230 |
Why?
|
| CD40 Antigens | 2 | 2019 | 60 | 0.230 |
Why?
|
| Interferon Regulatory Factor-7 | 3 | 2018 | 33 | 0.220 |
Why?
|
| Escherichia coli | 2 | 2020 | 685 | 0.220 |
Why?
|
| T-Lymphocytes | 4 | 2021 | 965 | 0.220 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 2019 | 243 | 0.220 |
Why?
|
| Bone Marrow Cells | 2 | 2018 | 231 | 0.210 |
Why?
|
| Arthritis | 1 | 2023 | 50 | 0.200 |
Why?
|
| Mammals | 1 | 2024 | 204 | 0.200 |
Why?
|
| Extracellular Matrix | 1 | 2023 | 130 | 0.200 |
Why?
|
| Liver Diseases | 1 | 2023 | 137 | 0.200 |
Why?
|
| Interleukin-6 | 3 | 2018 | 309 | 0.200 |
Why?
|
| Chemokine CXCL10 | 2 | 2019 | 60 | 0.200 |
Why?
|
| Lung Diseases | 1 | 2023 | 164 | 0.200 |
Why?
|
| Antigen Presentation | 3 | 2011 | 228 | 0.200 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 1221 | 0.190 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 256 | 0.190 |
Why?
|
| Macrophages | 4 | 2021 | 1007 | 0.190 |
Why?
|
| Heart Diseases | 1 | 2023 | 204 | 0.190 |
Why?
|
| Autocrine Communication | 2 | 2014 | 31 | 0.190 |
Why?
|
| Stem Cell Transplantation | 1 | 2021 | 75 | 0.180 |
Why?
|
| Multipotent Stem Cells | 1 | 2021 | 12 | 0.180 |
Why?
|
| Bacteria | 1 | 2024 | 276 | 0.180 |
Why?
|
| Macrophage Activation | 1 | 2021 | 119 | 0.180 |
Why?
|
| Bacteriuria | 1 | 2020 | 11 | 0.180 |
Why?
|
| Transplantation Tolerance | 1 | 2021 | 65 | 0.180 |
Why?
|
| Antibody Formation | 1 | 2020 | 111 | 0.180 |
Why?
|
| Dysbiosis | 1 | 2021 | 56 | 0.180 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 169 | 0.170 |
Why?
|
| Wound Healing | 1 | 2021 | 177 | 0.170 |
Why?
|
| Graft vs Host Disease | 1 | 2021 | 99 | 0.170 |
Why?
|
| Inflammasomes | 1 | 2023 | 331 | 0.170 |
Why?
|
| Molecular Mimicry | 1 | 2019 | 35 | 0.170 |
Why?
|
| Myocardium | 1 | 2021 | 262 | 0.170 |
Why?
|
| Stem Cells | 1 | 2021 | 257 | 0.160 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2021 | 275 | 0.160 |
Why?
|
| Genetic Variation | 1 | 2021 | 367 | 0.160 |
Why?
|
| Transcriptome | 2 | 2021 | 326 | 0.160 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 70 | 0.160 |
Why?
|
| Kallikrein-Kinin System | 1 | 2018 | 1 | 0.150 |
Why?
|
| Cell Death | 1 | 2019 | 268 | 0.150 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 351 | 0.150 |
Why?
|
| Bradykinin | 1 | 2018 | 8 | 0.150 |
Why?
|
| Nitric Oxide | 1 | 2019 | 145 | 0.150 |
Why?
|
| Lymph Nodes | 1 | 2019 | 212 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 185 | 0.150 |
Why?
|
| Plants | 1 | 2017 | 42 | 0.140 |
Why?
|
| Transcriptional Activation | 2 | 2018 | 188 | 0.140 |
Why?
|
| Nucleotidyltransferases | 1 | 2017 | 54 | 0.140 |
Why?
|
| Benzhydryl Compounds | 1 | 2017 | 48 | 0.140 |
Why?
|
| Estrogens | 1 | 2017 | 113 | 0.140 |
Why?
|
| Phenols | 1 | 2017 | 74 | 0.130 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2017 | 220 | 0.130 |
Why?
|
| Cell Nucleus | 1 | 2019 | 603 | 0.130 |
Why?
|
| Mesangial Cells | 1 | 2015 | 2 | 0.130 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 15 | 0.130 |
Why?
|
| Phagocytosis | 2 | 2008 | 252 | 0.130 |
Why?
|
| Chemokine CCL2 | 1 | 2015 | 54 | 0.130 |
Why?
|
| Immunity | 1 | 2016 | 96 | 0.120 |
Why?
|
| Male | 8 | 2021 | 27578 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 864 | 0.120 |
Why?
|
| Escherichia coli Infections | 1 | 2015 | 87 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2014 | 62 | 0.110 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2014 | 5 | 0.110 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2014 | 14 | 0.110 |
Why?
|
| Cell Differentiation | 2 | 2017 | 1295 | 0.110 |
Why?
|
| Melanoma, Experimental | 1 | 2014 | 42 | 0.110 |
Why?
|
| Ubiquitins | 1 | 2014 | 41 | 0.110 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2011 | 43 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 1131 | 0.090 |
Why?
|
| Endocytosis | 1 | 2011 | 148 | 0.090 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2009 | 31 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2017 | 581 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2015 | 618 | 0.080 |
Why?
|
| Glomerulonephritis | 1 | 2009 | 30 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 645 | 0.080 |
Why?
|
| Necrosis | 1 | 2009 | 138 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 552 | 0.080 |
Why?
|
| HIV-1 | 1 | 2014 | 708 | 0.080 |
Why?
|
| Parasitic Diseases, Animal | 1 | 2007 | 1 | 0.070 |
Why?
|
| Myxovirus Resistance Proteins | 1 | 2007 | 5 | 0.070 |
Why?
|
| Receptors, Interferon | 1 | 2007 | 19 | 0.070 |
Why?
|
| Genetic Vectors | 1 | 2014 | 813 | 0.070 |
Why?
|
| Interleukin-15 | 1 | 2007 | 21 | 0.070 |
Why?
|
| GTP-Binding Proteins | 1 | 2007 | 80 | 0.070 |
Why?
|
| Histocompatibility Antigens | 1 | 2007 | 107 | 0.070 |
Why?
|
| Interleukin-12 | 2 | 2018 | 124 | 0.070 |
Why?
|
| Genetic Therapy | 1 | 2014 | 735 | 0.070 |
Why?
|
| HIV Infections | 1 | 2014 | 921 | 0.070 |
Why?
|
| Immunophenotyping | 1 | 2007 | 191 | 0.070 |
Why?
|
| Virus Diseases | 1 | 2007 | 110 | 0.070 |
Why?
|
| Kinetics | 1 | 2008 | 733 | 0.070 |
Why?
|
| B7-2 Antigen | 1 | 2006 | 32 | 0.070 |
Why?
|
| B7-1 Antigen | 1 | 2006 | 73 | 0.060 |
Why?
|
| Mercuric Chloride | 1 | 2005 | 6 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 184 | 0.060 |
Why?
|
| Disease Susceptibility | 1 | 2006 | 158 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 2 | 2021 | 880 | 0.060 |
Why?
|
| Mice, 129 Strain | 2 | 2015 | 40 | 0.060 |
Why?
|
| Time Factors | 1 | 2012 | 3579 | 0.060 |
Why?
|
| Cell Line | 1 | 2008 | 2015 | 0.060 |
Why?
|
| Bacteroidetes | 1 | 2023 | 5 | 0.050 |
Why?
|
| Amyloidogenic Proteins | 1 | 2023 | 11 | 0.050 |
Why?
|
| B-Lymphocytes | 2 | 2022 | 550 | 0.050 |
Why?
|
| Immunity, Mucosal | 1 | 2023 | 46 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2017 | 671 | 0.050 |
Why?
|
| Peptides | 1 | 2006 | 549 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2023 | 265 | 0.050 |
Why?
|
| Germinal Center | 1 | 2022 | 35 | 0.050 |
Why?
|
| Cortical Bone | 1 | 2021 | 1 | 0.050 |
Why?
|
| Swine, Miniature | 1 | 2021 | 8 | 0.050 |
Why?
|
| Drug Repositioning | 1 | 2021 | 6 | 0.050 |
Why?
|
| Videoconferencing | 1 | 2021 | 12 | 0.050 |
Why?
|
| Ubiquinone | 1 | 2021 | 16 | 0.050 |
Why?
|
| Congresses as Topic | 1 | 2021 | 73 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 1449 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 97 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 85 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2005 | 759 | 0.040 |
Why?
|
| Swine | 1 | 2021 | 344 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 142 | 0.040 |
Why?
|
| Metformin | 1 | 2021 | 67 | 0.040 |
Why?
|
| Aging | 1 | 2006 | 723 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2005 | 842 | 0.040 |
Why?
|
| Catheter-Related Infections | 1 | 2020 | 40 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2021 | 370 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2023 | 710 | 0.040 |
Why?
|
| Epitopes | 1 | 2020 | 298 | 0.040 |
Why?
|
| Child | 2 | 2021 | 4306 | 0.040 |
Why?
|
| Tissue Kallikreins | 1 | 2018 | 2 | 0.040 |
Why?
|
| Captopril | 1 | 2018 | 8 | 0.040 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2017 | 15 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 1095 | 0.040 |
Why?
|
| Adolescent | 2 | 2021 | 5932 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 1373 | 0.030 |
Why?
|
| Infant | 1 | 2021 | 1527 | 0.030 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2015 | 5 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2017 | 348 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 694 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 1839 | 0.030 |
Why?
|
| Polymerization | 1 | 2015 | 35 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2014 | 50 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 2442 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 526 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 159 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 145 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2005 | 502 | 0.030 |
Why?
|
| Middle Aged | 2 | 2020 | 16279 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2014 | 305 | 0.030 |
Why?
|
| Ovalbumin | 1 | 2011 | 114 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 484 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 149 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 138 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 4332 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 5017 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 595 | 0.020 |
Why?
|
| Survival Rate | 1 | 2009 | 791 | 0.020 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2006 | 3 | 0.020 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2006 | 5 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 2006 | 33 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 960 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2006 | 66 | 0.020 |
Why?
|
| Transmembrane Activator and CAML Interactor Protein | 1 | 2005 | 2 | 0.020 |
Why?
|
| B-Cell Activating Factor | 1 | 2005 | 9 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2005 | 84 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2005 | 61 | 0.020 |
Why?
|
| Binding Sites, Antibody | 1 | 2005 | 29 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2005 | 35 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2005 | 36 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2005 | 85 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 106 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2006 | 194 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2006 | 344 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 13346 | 0.010 |
Why?
|
| Vaccines | 1 | 2006 | 97 | 0.010 |
Why?
|
| Disease Progression | 1 | 2009 | 1044 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 354 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 15791 | 0.010 |
Why?
|
| Histones | 1 | 2005 | 463 | 0.010 |
Why?
|
| Chromatin | 1 | 2005 | 594 | 0.010 |
Why?
|
| Neoplasms | 1 | 2006 | 1243 | 0.010 |
Why?
|